Bio-Techne Corporation

$59.22 ▼ -0.75%

2026-04-22 10:12:13

Explore Bio-Techne Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap

$9.33 B

Current Price

$59.22

52W High / Low

$72.16 / $46.01

Stock P/E

116.91

Book Value

$12.9

Dividend Yield

0.53%

ROCE

10.19%

ROE

3.97%

Face Value

—

EPS

$0.51

Exp Qtr EPS

—

Sector

Healthcare

Industry

Biotechnology

Employees

3,100

Beta

1.49

Debt / Equity

17.45

Current Ratio

4.54

Quick Ratio

2.38

Forward P/E

25.67

Price / Sales

7.15

Enterprise Value

$8.86 B

EV / EBITDA

26.81

EV / Revenue

7.29

Rating

Buy

Target Price

$73.64

EPS Forecast (FY)

—

ABOUT

In essence, bio-Techne Corporation, together with its subsidiaries, is focused on developing, handles the manufacturing of, and markets and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. In essence, this organization conducts operations through two segments, Protein Sciences, and Diagnostics and Spatial Biology. In essence, the Protein Sciences segment is focused on developing and handles the manufacturing of biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. In essence, this segment also delivers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. In essence, the Diagnostics and Genomics segment is focused on developing and handles the manufacturing of diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and markets and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. In essence, this organization was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. In essence, bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. ROE at 3.68% based on the latest available annual data. ROCE at 10.19% using operating income and capital employed. Debt to equity stands at 0.23x. Operating margin is 19.67% on trailing numbers. Trailing twelve month sales are available in the dataset.

Pros

Balance sheet leverage appears manageable.
Short-term liquidity looks comfortable.
Strong operating margin profile.
Meaningful dividend yield is available.

Cons

Return on equity is on the weaker side.
Valuation is rich on a P/E basis.

Sift Stocks

S.No.	Name	Price	P.E.	Market Cap	Div Yld %	ROCE	ROE	52Week High/ Low	Book Value
1.	SeaStar Medical Holding Corporation	$4.63	—	$16.77 M	—	-116.89%	-2.95%	$13.4 / $2.07	$2.71
2.	NeOnc Technologies Holdings, Inc.	$5.17	—	$133.03 M	—	129%	122.08%	$12.99 / $3.2	$-0.81
3.	NRx Pharmaceuticals, Inc.	$3.2	—	$105.82 M	—	103.85%	146.18%	$3.84 / $1.62	$-0.5
4.	Oramed Pharmaceuticals Inc.	$3.83	3.45	$151.27 M	0%	-7.12%	37.1%	$3.96 / $1.98	$4.98
5.	PTC Therapeutics, Inc.	$72.32	8.72	$5.95 B	—	44.37%	-104.75%	$87.5 / $35.95	$-2.52
6.	Janux Therapeutics, Inc.	$15.87	—	$962.36 M	—	-16.15%	-11.48%	$35.34 / $12.12	$15.85
7.	LeonaBio, Inc.	$9.38	—	$83.23 M	—	-76.55%	-2.91%	$14.21 / $2.2	$5.2

Quarterly Results

Figures shown in M / B

	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024
Sales	295.88 M	286.56 M	316.96 M	316.18 M	297.03 M
Operating Profit	54.46 M	47.66 M	116.69 M	38.71 M	47.42 M
Net Profit	38.01 M	38.19 M	-17.68 M	22.59 M	34.89 M
EPS in Rs	0.24	0.24	-0.11	0.14	0.22

Profit & Loss

Figures shown in M / B

	2025	2024	2023	2022
Sales	1.22 B	1.16 B	1.14 B	1.11 B
Operating Profit	242.8 M	246.4 M	291 M	295.83 M
Net Profit	73.4 M	168.1 M	285.26 M	272.05 M
EPS in Rs	0.47	1.07	1.82	1.74

Balance Sheet

Figures shown in M / B

	2025	2024	2023	2022
Total Assets	2.56 B	2.7 B	2.64 B	2.29 B
Total Liabilities	639.06 M	635.02 M	672.18 M	593.79 M
Equity	1.92 B	2.07 B	1.97 B	1.7 B
Current Assets	608.3 M	617.42 M	621.48 M	605.56 M
Current Liabilities	175.85 M	159.38 M	128.51 M	176.02 M

Cash Flow

Last available yearly cash flow history

	2025	2024	2023	2022
Operating CF	287.56 M	298.98 M	254.39 M	325.27 M
Investing CF	-35.18 M	-203.03 M	-265.65 M	-96.85 M
Financing CF	-253.91 M	-122.4 M	22.62 M	-242.85 M
Free CF	256.55 M	236.1 M	216.15 M	280.36 M
Capex	-31.01 M	-62.88 M	-38.24 M	-44.91 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

	2025	2024	2023	2022
Revenue Growth %	5.23%	1.97%	2.81%	—
Earnings Growth %	-56.34%	-41.07%	4.86%	—
Profit Margin %	6.02%	14.5%	25.1%	24.61%
Operating Margin %	19.91%	21.26%	25.6%	26.76%
Gross Margin %	64.8%	66.41%	67.72%	68.42%
EBITDA Margin %	17.78%	27.02%	40.21%	37.42%

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

Ex Date	Dividend
2026-02-13	$0.08
2025-11-17	$0.08
2025-08-18	$0.08
2025-05-19	$0.08
2025-02-14	$0.08
2024-11-08	$0.08
2024-08-19	$0.08
2024-05-10	$0.08
2024-02-09	$0.08
2023-11-09	$0.08
2023-08-17	$0.08
2023-05-12	$0.08
2023-02-10	$0.08
2022-11-10	$0.08
2022-08-12	$0.08
2022-05-13	$0.08
2022-02-10	$0.08
2021-11-10	$0.08
2021-08-13	$0.08
2021-05-14	$0.08

Stock Splits

Date	Split
2022-11-30	1:4

Shareholding Pattern

Shares and value shown in M / B

Holder Name	Type	Shares	Value	% Out	Report Date
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund	Mutual Fund	2.72 M	$144.52 M	0.02%	2026-01-31
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF	Mutual Fund	2.62 M	$139.22 M	0.02%	2026-01-31
Vanguard Explorer Fund	Mutual Fund	2.27 M	$120.87 M	0.01%	2026-01-31
iShares Trust-iShares Core S&P 500 ETF	Mutual Fund	2.01 M	$107.05 M	0.01%	2026-01-31
Vanguard Group Inc	Institutional	17.81 M	$946.29 M	0.11%	2025-12-31
Blackrock Inc.	Institutional	12.13 M	$644.42 M	0.08%	2025-12-31
Morgan Stanley	Institutional	8.35 M	$443.39 M	0.05%	2025-12-31
State Street Corporation	Institutional	5.81 M	$308.79 M	0.04%	2025-12-31
Wellington Management Group, LLP	Institutional	5.73 M	$304.65 M	0.04%	2025-12-31
Geode Capital Management, LLC	Institutional	4.93 M	$261.92 M	0.03%	2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	Mutual Fund	4.91 M	$261.06 M	0.03%	2025-12-31
Price (T.Rowe) Associates Inc	Institutional	4.08 M	$216.52 M	0.03%	2025-12-31
Massachusetts Financial Services Co.	Institutional	4.01 M	$213.2 M	0.03%	2025-12-31
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund	Mutual Fund	3.93 M	$208.75 M	0.03%	2025-12-31
Maverick Capital Ltd.	Institutional	3.85 M	$204.6 M	0.02%	2025-12-31